Abstract
About this talk
About 90% of all compounds in the pharmaceutical drug market have solubility in water. About 60% of people over 60 and 40% of all ages have struggled to take solid medicines, such as tablets or capsules. We have developed new pharmacology with our NutraNanoSpheres™ (NNS) approach by miscellizing nutraceuticals, pharmaceuticals, and peptides to form stable NNS products. The NNS are completely soluble in water and are heat stable. We use a natural fatty acid without organic solvents to encapsulate nutraceuticals in sub-microscopic "micelles" in which over 500 can stretch across a human red cell as for curcumin. The NNS are not degraded in the stomach, pass into the bloodstream, and can cross the blood-brain barrier to offer high bioavailability. We have used a variety of NNS formulations to cure Malaria using an in vivo vaccination process in babies, treat antiviral assaults, provide formulations for cancer, heart disease, brain dysfunction, and energy enhancement. The NNS offer time-released mixtures of compounds that operate synergistically with the assurance that the NNS are stable and do not interact with each other. Examples of our applications of this technology include multilayered NNS for time-released Vitamin C, water-soluble antimalaria treatment for babies provided a milk bottle with a 93% cure rate, rapid recovery from severe COVID-19, a brain energy formulation, and treatment of Choline deficiency in pregnant women.
Speaker
About the speaker
